Canbud Distribution Corporation (CSE: CBDX) (FSE: CD0) (“Canbud” or the “Corporation”) is pleased to announce its subsidiary, Empathy Plant Co. has signed certified plant-based nutritionist, Melissa Melnychuk as their official spokesperson.

Melissa is a Certified Holistic Health Coach (CHHC) and is also a Plant-Based Certified expert from Cornell University. Melissa started her practice in 2010 and has worked with women from all walks of life including entrepreneurs, traveling executives, stay-at-home moms, former fitness competitors, professional athletes and more. As a mother of 3 and former fitness athlete, Melissa understands how to balance a holistic and busy lifestyle. As an advocate for body positivity and the ‘diet culture dropout’ movement, she reflects the Empathy Plant Co. culture and messaging tone of inclusivity and change through thoughtful conversations.


Cannot view this image? Visit: https://orders.newsfilecorp.com/files/7448/78826_1e283885c445f8a9_001.jpg

Melissa Melnychuk

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/7448/78826_1e283885c445f8a9_001full.jpg

Melissa comments: “When I was approached to help support and build the Empathy Plant Co. brand I jumped at the opportunity.”

“Not only am I familiar with the entrepreneurial team behind the brand, but their character and vision are something I am completely aligned with.”

“Other current plant-based protein offerings are not speaking to the largest target market and the team has given me the opportunity to do so. The more people I can turn on to the plant-based lifestyle, the more people I can help and that fuels my soul.”

“With the Canbud and Empathy team by my side I’m stoked to help people live healthier and happy lives.”

As part of Empathy Plant Co.’s marketing strategy, Melissa will be responsible for speaking to and influencing the largest segment in the plant-based space, 18 to 24-year-old females who account for 48% of the market (PLANT-BASED FOOD & DRINK CANADA, MAY 2019).

Melissa will take an active role in promoting the benefits of incorporating plant-based into people’s dietary habits and help champion the movement. As Empathy Plant Co. pushes to commercialize, the credibility of her accomplishments will help build consumer confidence, trust, drive recurring sales and bring value to the end user.

Canbud VP of Marketing and CPG (Consumer Packaged Goods) expert, Adrian Burke comments: “I have known Melissa for over a decade and have watched her execute at a high level as a savvy business person. Her passion for helping others is something that stands out the most, along with her caring and nurturing qualities, she has given me all the confidence she’ll appeal greatly to the largest segment of plant-based consumers.”

Empathy will also be leveraging Melissa’s experience and insight in exploring plant-based drink options further enriching their innovation pipeline. With the production of their Complete Plant Protein well under way, Empathy Plant Co. is strongly positioned in the plant-based product segment which is anticipated to witness the fastest growth in the protein market over the forecasted period (2020-2027).

According to a new market research report titled, “Plant Based Protein Supplements Market by Type (Soy Protein, Rice Protein), Form (Powder, RTD), Application (Sport Nutrition, Additional Nutrition), and Distribution Channel (Hypermarket/Supermarket, E-Commerce, Pharmacies) – Global Forecast to 2027”, published by Meticulous Research®, the plant-based protein supplements market is expected to grow at a CAGR of 7.8% from 2020 to 2027 to reach $9.57 billion by 2027.

Follow all Empathy Plant Co. developments by entering your email at empathyplantco.com or following on Instagram.com/empathyplantco.

Consulting Options:

The Corporation has granted 600,000 incentive stock options to 2 consultants of the Corporation. The options have an exercise price of 22 cents and a term of four years expiring on March 30, 2025.

About Canbud Distribution Corporation

Canbud Distribution Corporation is a science and technology health and wellness company that encompasses plant based, psychedelic pharmaceutical and non-psychedelic nutraceutical, and hemp cannabinoids (CBD) verticals.

www.canbudcorp.com
https://www.instagram.com/canbudcorp/?hl=en
https://twitter.com/canbudcorp

https://www.linkedin.com/company/canbud-distribution-corp/?viewAsMember=true
https://www.instagram.com/empathyplantco/?hl=en

For further information, please contact:
ir@canbudcorp.com
or
Robert Tjandra, President and COO
Tel: 1 416 847 7312

Notice Regarding Forward-Looking Information

This news release is not an offer to sell, or a solicitation of an offer to buy or sell, any securities of the Corporation and may not be relied upon in connection with the purchase or sale of any such security.

This news release contains “forward-looking information” within the meaning of Canadian securities legislation. The forward-looking information contained in this news release represents the expectations of the Corporation as of the date of this news release and, accordingly, is subject to change after such date. Forward-looking information includes information including statements with respect to the future exploration performance of the Corporation. Forward-looking information is based on, among other things, opinions, assumptions, estimates and analyses that, while considered reasonable by the Corporation at the date the forward-looking information is provided, are inherently subject to significant risks, uncertainties, contingencies and other factors that may cause actual results and events to be materially different from those expressed or implied by the forward-looking information. The risks, uncertainties, contingencies and other factors that may cause actual results to differ materially from those expressed or implied by the forward-looking information may include, but are not limited to (i) adverse market conditions; (ii) risks inherent in the CBD, psychedelics and vegan protein industries in general or (iii) risks generally associated with the Corporation’s business, as described in the Corporation’s public filings on SEDAR, which readers are encouraged to review in detail prior to any transaction involving the securities of the Corporation. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Corporation does not intend to update these forward-looking statements. Readers should not place undue importance on forward-looking information and should not rely upon this information as of any other date.

Not for distribution to U.S. news wire services or dissemination in the United States.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/78826

News Provided by Newsfile via QuoteMedia

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less